Free Trial
NASDAQ:NRXS

NeurAxis (NRXS) Stock Price, News & Analysis

NeurAxis logo
$3.18 -0.01 (-0.31%)
Closing price 10/3/2025 04:00 PM Eastern
Extended Trading
$3.18 +0.00 (+0.16%)
As of 10/3/2025 06:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About NeurAxis Stock (NASDAQ:NRXS)

Advanced

Key Stats

Today's Range
$3.15
$3.25
50-Day Range
$2.31
$3.19
52-Week Range
$1.33
$6.20
Volume
43,009 shs
Average Volume
564,884 shs
Market Capitalization
$31.40 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.00
Consensus Rating
Buy

Company Overview

NeurAxis Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
40th Percentile Overall Score

NRXS MarketRank™: 

NeurAxis scored higher than 40% of companies evaluated by MarketBeat, and ranked 692nd out of 941 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    NeurAxis has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Upside Potential

    NeurAxis has a consensus price target of $7.00, representing about 120.1% upside from its current price of $3.18.

  • Amount of Analyst Coverage

    NeurAxis has received no research coverage in the past 90 days.

  • Read more about NeurAxis' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of NeurAxis is -1.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of NeurAxis is -1.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about NeurAxis' valuation and earnings.
  • Percentage of Shares Shorted

    0.64% of the float of NeurAxis has been sold short.
  • Short Interest Ratio / Days to Cover

    NeurAxis has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in NeurAxis has recently increased by 6.76%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    NeurAxis does not currently pay a dividend.

  • Dividend Growth

    NeurAxis does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.64% of the float of NeurAxis has been sold short.
  • Short Interest Ratio / Days to Cover

    NeurAxis has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in NeurAxis has recently increased by 6.76%, indicating that investor sentiment is decreasing significantly.
    • Insider Buying vs. Insider Selling

      In the past three months, NeurAxis insiders have not sold or bought any company stock.

    • Percentage Held by Insiders

      26.40% of the stock of NeurAxis is held by insiders. A high percentage of insider ownership can be a sign of company health.

    • Percentage Held by Institutions

      Only 11.77% of the stock of NeurAxis is held by institutions.

    • Read more about NeurAxis' insider trading history.
    Receive NRXS Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for NeurAxis and its competitors with MarketBeat's FREE daily newsletter.

    By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

    NRXS Stock News Headlines

    Tilson: “I’m watching HOOD”
    A strange chasm is coming to Wall Street... It's already creating millionaires and billionaires at the fastest pace in history. CNBC calls it "the largest wealth creation spree in history." Yet 1 in 3 Americans now fear their financial situation is deteriorating. There's only one way to survive, says the man who predicted 2008 and 2020, but sadly it's already too late for many.tc pixel
    NeurAxis, Inc. (NRXS) Q2 2025 Earnings Call Transcript
    Earnings Outlook For Neuraxis
    See More Headlines

    NRXS Stock Analysis - Frequently Asked Questions

    NeurAxis' stock was trading at $2.35 at the beginning of 2025. Since then, NRXS stock has increased by 35.3% and is now trading at $3.18.

    NeurAxis, Inc. (NASDAQ:NRXS) posted its earnings results on Tuesday, November, 12th. The company reported ($0.25) EPS for the quarter. The business earned $0.67 million during the quarter.

    NeurAxis (NRXS) raised $7 million in an initial public offering (IPO) on Wednesday, August 9th 2023. The company issued 1,098,667 shares at a price of $6.00 per share.

    Shares of NRXS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

    Based on aggregate information from My MarketBeat watchlists, some other companies that NeurAxis investors own include AutoZone (AZO), Intel (INTC), Meta Platforms (META), Outdoor (POWW), SPDR S&P 500 ETF Trust (SPY), TJX Companies (TJX) and ETRACS Crude Oil Shares Covered Call ETN (USOI).

    Company Calendar

    Last Earnings
    11/12/2024
    Today
    10/05/2025
    Next Earnings (Estimated)
    11/11/2025
    Fiscal Year End
    12/31/2025

    Industry, Sector and Symbol

    Stock Exchange
    NASDAQ
    Sector
    Medical
    Industry
    Electromedical equipment
    Sub-Industry
    Medical Equipment
    Current Symbol
    NASDAQ:NRXS
    CIK
    1933567
    Fax
    N/A
    Employees
    19
    Year Founded
    2011

    Price Target and Rating

    High Price Target
    $7.00
    Low Price Target
    $7.00
    Potential Upside/Downside
    +120.1%
    Consensus Rating
    Buy
    Rating Score (0-4)
    3.00
    Research Coverage
    1 Analysts

    Profitability

    EPS (Trailing Twelve Months)
    ($0.99)
    Trailing P/E Ratio
    N/A
    Forward P/E Ratio
    N/A
    P/E Growth
    N/A
    Net Income
    -$14.63 million
    Net Margins
    -492.76%
    Pretax Margin
    -341.35%
    Return on Equity
    N/A
    Return on Assets
    -641.25%

    Debt

    Debt-to-Equity Ratio
    N/A
    Current Ratio
    0.24
    Quick Ratio
    0.23

    Sales & Book Value

    Annual Sales
    $3.22 million
    Price / Sales
    9.76
    Cash Flow
    N/A
    Price / Cash Flow
    N/A
    Book Value
    ($0.27) per share
    Price / Book
    -11.78

    Miscellaneous

    Outstanding Shares
    9,873,000
    Free Float
    6,085,000
    Market Cap
    $31.40 million
    Optionable
    Not Optionable
    Beta
    3.18

    Social Links

    Reduce the Risk Cover

    Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

    Get This Free Report

    This page (NASDAQ:NRXS) was last updated on 10/6/2025 by MarketBeat.com Staff
    From Our Partners